Tegretol

   
Google
 
Web NewDrugInformation.com

Tegretol


Drug - Tegretol
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Carbamazepine
Multiple ingredients are in alphabetical order.

Strength - 200MG
The potency of the active ingredient(s), Carbamazepine. May repeat for multiple part products.

Applicant - NOVARTIS
The firm name holding legal responsibility for Tegretol. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 016608
The FDA assigned number to Tegretol. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Tegretol. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Tegretol was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Tegretol. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Tegretol is in. Format is RX, OTC, DISCN.

Applicant Full Name - Novartis Pharmaceuticals Corp
The full name of the firm holding legal responsibility for the new application of Tegretol.

Tegretol